ダウンロード数: 464

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
34_301.pdf212.15 kBAdobe PDF見る/開く
タイトル: インポテンツに対する血管拡張剤の使用経験
その他のタイトル: Intracavernous injection of vasoactive drugs for treating erectile impotence
著者: 安本, 亮二  KAKEN_name
浅川, 正純  KAKEN_name
川嶋, 秀紀  KAKEN_name
吉村, 力勇  KAKEN_name
前川, たかし  KAKEN_name
柏原, 昇  KAKEN_name
田中, 寛  KAKEN_name
西尾, 正一  KAKEN_name
著者名の別形: YASUMOTO, Ryoji
ASAKAWA, Masazumi
KAWASHIMA, Hidenori
YOSHIMURA, Rikio
MAEKAWA, Takashi
KASHIWARA, Noboru
TANAKA, Hiroshi
NISHIO, Shoichi
キーワード: Impotence
Vasoactive drugs
発行日: Feb-1988
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 34
号: 2
開始ページ: 301
終了ページ: 304
抄録: Intracavernous injection of various vasoactive drugs was performed in six erectile failure patients. The effects of each drug were evaluated in four grades: complete functional erection, incomplete functional erection, nonfunctional expansion and no effect. When papaverine hydrochloride (40 mg/ml) was administered, 4 of the 6 patients had nonfunctional expansion. By administering a mixture of 80 mg/ml papaverine hydrochloride with 1.0 mg/ml phentolamine mesylate, nonfunctional expansion was seen in four patients and incomplete functional erection in two patients. As for the effects of prostaglandin E1, incomplete functional erections were seen in all patients, while complete functional erection was seen in two patients. These findings indicated that the patients reacted differently to the same vasoactive drug, and that the papaverine and phentolamine mixture had a stronger effect than papaverine alone, while prostaglandin E1 had the strongest effect on erection. Intracavernous injection of the these drugs is useful for the treatment and differential diagnosis of impotence.
URI: http://hdl.handle.net/2433/119464
PubMed ID: 2454019
出現コレクション:Vol.34 No.2

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。